SUN PHARMACEUTICAL IND L vs Transpact Enterprises Ltd
A side-by-side comparison of SUN PHARMACEUTICAL IND L (SUNPHARMA) and Transpact Enterprises Ltd (TRANSPACTENTERPRISESLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, SUN PHARMACEUTICAL IND L leads SUNPHARMA vs TRANSPACTENTERPRISESLTD on 9 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation31
- Profitability22
- Growth10
- Size & financial health31
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
SUNPHARMA takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
EvenHow efficiently each company turns capital and sales into profit. Higher is better.
Growth
SUNPHARMA takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
SUNPHARMA takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
- − ["The company has delivered a poor sales growth of 11.8% over past five years."]
- + ["Company has reduced debt."]
- − ["Stock is trading at 6.14 times its book value", "Though the company is reporting repeated profits, it is not paying out dividend", "Promoter holding is low: 16.2%", "Company has a low return on equity of 0.70% over last 3 years.", "Company has high debtors of 203 days.", "Promoter holding has decreased over last 3 years: -16.5%"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.